Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
treatment source : Www.vbivaccines.com save search
VBI Vaccines Partner Brii Biosciences Announces Topline Interim Results of Phase 2 Study Evaluating BRII-179 (VBI-2601) in Combination With PEG-IFNα for the Treatment of Chronic Hepatitis B
Published: 2023-09-06 (Crawled : 12:00) - vbivaccines.com
CYDY | $0.148 0.06% 1.5M
|
Manufacturing
|
| O: 0.49%
H: 1.94%
C: 1.94%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
VBIV | $0.591 -4.68% -4.91% 370K
|
Health Technology
|
| O: 0.81%
H: 0.8%
C: -2.4%
TRIB | $1.855 1.08% 3.1K
|
Health Technology
|
| O: -0.38%
H: 1.87%
C: 1.86%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.83%
H: 0.19%
C: -0.09%
RGEN | News | $160.96 -1.96% -1.99% 520K
|
Health Technology
|
| O: -0.47%
H: 0.45%
C: -0.51%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: -1.56%
H: 0.0%
C: 0.0%
AVID | $27.04 0.07% 630K
|
Technology Services
|
| O: 0.26%
H: 0.37%
C: 0.26%
brii-179 hepatitis treatment topline results study
VBI Vaccines Granted FDA Fast Track Designation for VBI-1901 for the Treatment of Recurrent GBM
Published: 2021-06-08 (Crawled : 12:00) - vbivaccines.com
VBIV | $0.591 -4.68% -4.91% 370K
|
Health Technology
|
| O: 4.62%
H: 9.67%
C: 9.39%
AGEN | News | $5.385 -14.52% -16.99% 1.5M
|
Health Technology
|
| O: 1.87%
H: 14.68%
C: 14.45%
treatment fda fda fast track fast track vaccine fast track designation granted grant designation
Brii Biosciences, Vir Biotechnology, and VBI Vaccines Announce Initiation of Phase 2 Clinical Trial of BRII-835 (VIR-2218) in Combination with BRII-179 (VBI-2601) for the Treatment of Hepatitis B
Published: 2021-04-21 (Crawled : 12:00) - vbivaccines.com
VIR | $8.255 -1.26% -1.27% 760K
|
Health Technology
|
| O: -1.09%
H: 0.38%
C: 0.04%
VBIV | $0.591 -4.68% -4.91% 370K
|
Health Technology
|
| O: 0.0%
H: 7.66%
C: 7.66%
ALNY | $145.23 -1.02% -1.03% 500K
|
Health Technology
|
| O: 0.67%
H: 1.12%
C: 0.43%
treatment phase 2 hepatitis vbi-2601 biotech vaccine technology iot brii-835 trial
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.